Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed

ATLANTA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced today a partnership with Medical Electronic Systems LLC (MES) to provide advanced sperm analysis technology. The FemSperm Analysis Kit completes the FemSperm product family, joining the Setup Kit and Insemination Prep Kit. Together, they expand Femasys’ infertility portfolio and, for the first time, enables gynecologists to perform in-office sperm preparation and analysis for use with its first-step infertility treatment, FemaSeed Intratubal Insemination.

Read more at globenewswire.com